The role of alternative splicing in lung disease
A continuing study on the molecular mechanisms underpinning pro and anti-inflammatory pathways in the lung, in particular, the role of alternative splicing in chronic inflammatory lung disease. New therapeutic approaches to treat severe asthma using antisense oligonucleotides are being explored.
To get involved or for more information, contact the Research Leader.
Dr Svetlana Baltic
BSc (Hons), MSc, PhD
Senior Research Fellow
Prof Philip Thompson
MBBS, FRACP,FCCP, MRACMA
Head of Molecular Genetics Unit